Uvulitis

Summary

Uvulitis (MONDO:0000739) is a disease. A subtype of upper respiratory tract disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	uvulitis
Mondo ID	MONDO:0000739
DOID	DOID:0060310
ICD-11	776797866
NCIT	C128385
SNOMED CT	300932000
UMLS	C0042174
MedGen	508266
MedDRA	10051962
Is cancer (heuristic)	no

Also known as: acute uvulitis · inflammation of palatine uvula · palatine uvula inflammation

Disease family

This is a subtype of upper respiratory tract disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › upper respiratory tract disorder › uvulitis

Related subtypes (9): adenoid hypertrophy, tonsillitis, acute laryngopharyngitis, nasal cavity disorder, pharyngitis, tracheal disorder, laryngeal disorder, nasopharyngeal disorder, epiglottitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.